Table 2.
AE* | HD cohort | LD cohort | Total | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Grade | Total | Grade | Total | |||||||
2 | 3 | 4 | 2 | 3 | 4 | 5 | ||||
Lymphocytopenia | 7 | 6 | 1 | 14 | 3 | 5 | 1 | — | 9 | 23 |
Upper respiratory tract infection | 7 | — | — | 7 | 14 | — | — | — | 14 | 21 |
Pneumonia | 5 | 2 | — | 7 | 4 | 4 | — | 1 | 9 | 16 |
Hypophosphatemia | 6 | 4 | — | 10 | 4 | 1 | — | — | 5 | 15 |
Fatigue† | 5 | 5 | — | 10 | 2 | 1 | — | — | 3 | 13 |
Maculopapular rash† | 4 | 1 | — | 5 | 7 | 1 | — | — | 8 | 13 |
Skin infection | 4 | 1 | — | 5 | 1 | 5 | — | — | 6 | 11 |
Neutropenia | 6 | 2 | 1 | 9 | 2 | — | — | — | 2 | 11 |
Anemia | 2 | 2 | — | 4 | 4 | — | — | — | 4 | 8 |
Limb edema | 2 | 1 | — | 3 | 4 | — | — | — | 4 | 7 |
Hypotension | 1 | 1 | — | 2 | 2 | 1 | 1 | — | 4 | 6 |
Skin ulceration† | 1 | — | — | 1 | 2 | 3 | — | — | 5 | 6 |
Increased alanine aminotransferase† | 2 | 1 | 1 | 4 | 2 | — | — | — | 2 | 6 |
Diarrhea† | 2 | 2 | — | 4 | 2 | — | — | — | 2 | 6 |
Tremor | 5 | — | — | 5 | 1 | — | — | — | 1 | 6 |
Hypertension | 1 | 1 | — | 2 | 3 | — | — | — | 3 | 5 |
Leukocytopenia | 2 | 1 | — | 3 | 2 | — | — | — | 2 | 5 |
Hypoalbuminemia | 2 | — | — | 2 | 3 | — | — | — | 3 | 5 |
Myalgia/muscle cramps† | 4 | — | — | 4 | 1 | — | — | — | 1 | 5 |
Nausea† | 3 | — | — | 3 | 2 | — | — | — | 2 | 5 |
The data cutoff was March 22, 2017. Multiple occurrences of the same AE in 1 subject were counted every time for corresponding grade.
AEs possibly related to cGVHD.